A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis

NCT02469467 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

End Stage Renal Disease
Hyperphosphatemia

Interventions

DIETARY_SUPPLEMENT: VS-505

Sponsor

KDL Inc.